Danish medical device company Brainreader has announced FDA approval for its Neuroreader MR software designed to quickly detect changes in a patient’s brain volume brought on by neurodegenerative diseases or traumatic brain injuries.
The process works by uploading MR images to Neuroreader, which compares them against an FDA-approved database of healthy brain scans. In a matter of minutes, the software can measure 45 different brain structures and report back on changes as small as hundredths of a millimeter, according to a company press release.
Radiologists could use the software to accurately detect abnormalities resulting from Alzheimer’s disease, depression, concussion or a number of other conditions.
Neuroreader is a software-as-a-service product sold either through a subscription or pay-per-use.